2026-08-10T01:37:27Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/75332024-09-27T10:06:19Zcom_20.500.12105_19604com_20.500.12105_2051col_20.500.12105_19607

00925njm 22002777a 4500 dc Camafeita, Emilio author Lamas, José Ramón author Calvo, Enrique author Tornero-Esteban, Pilar author Lopez, Juan Antonio author Fernandez-Gutierrez, Benjamin author 2014 Osteoarthritis (OA) is considered the most prevalent form of arthritis. The aim of this study was to verify potential protein OA biomarkers by applying Selected Reaction Monitoring (SRM) assays to protein extracts obtained from Bone Marrow-Mesenchymal Stem Cells (BM-MSCs) isolated from OA patients. BM aspirates were obtained from the femoral channel of OA patients at the time of surgery and from the femoral channel of hip fracture subjects without OA during hip joint replacement surgery for the treatment of subcapital fracture. SRM results verified the differential expression of several protein biomarkers in BM-MSCs from OA patients. Clin Proteomics. 2014; 11(1):33 10.1186/1559-0275-11-33 1542-6416 Clinical proteomics 25249828 http://hdl.handle.net/20.500.12105/7533 Mesenchymal stem cells Osteoarthritis Selected reaction monitoring Selected reaction monitoring assays in mesenchymal stem cells from osteoarthritis patients